Atonic bladder definition , causes treatment and management
Reading File
Finding Sources
Finding Sources
Searching PubMed
"atonic bladder" OR "neurogenic bladder" AND management
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive content from multiple authoritative textbooks. Let me compile the full, well-structured answer.
Atonic Bladder
Definition
An atonic bladder (also called flaccid bladder, areflexic bladder, or hypotonic bladder) is a condition in which the detrusor muscle of the bladder loses its normal contractile ability, resulting in failure to empty urine adequately. The bladder becomes overstretched, fills to capacity, and urine dribbles out passively - a phenomenon called overflow incontinence. The micturition reflex cannot occur because either afferent sensory signals from the bladder are disrupted or the efferent motor pathways are damaged.
In neurological classification, atonic bladder is a lower motor neuron (LMN) lesion type of neurogenic bladder. The key features are an areflexic or hyporeflexic detrusor with preserved coordination between the detrusor and external urethral sphincter, and characteristically low bladder pressures.
Pathophysiology
Normal micturition depends on an intact sacral reflex arc (S2-S4). Stretch receptors in the bladder wall sense filling and transmit afferent signals via pelvic nerves to the sacral cord. Efferent parasympathetic fibers then cause detrusor contraction and sphincter relaxation. Atonic bladder results from disruption at any point in this arc:
- Destruction of sensory (afferent) nerve fibers: The stretch signals from the bladder never reach the cord, so the micturition reflex cannot be triggered. The bladder simply fills to capacity and overflows. (Guyton & Hall, p.334)
- Damage to motor (efferent) fibers or sacral cord: The detrusor cannot contract even if stretch is sensed.
- Repeated overdistension: Mechanical over-stretching of the detrusor leads to fibrosis and permanent atonia or hypotonia. (Adams & Victor's Principles of Neurology)
Causes
Neurological Causes
| Category | Specific Examples |
|---|---|
| Spinal cord injury | Crush injury to the sacral region (conus medullaris or below); LMN lesion below S2-S4 |
| Cauda equina syndrome | Compression/injury of lumbar/sacral roots - produces distended atonic bladder with urinary retention |
| Tabes dorsalis (syphilis) | Constrictive fibrosis around dorsal root nerve fibers destroys sensory afferents ("tabetic bladder") |
| Diabetes mellitus | Autonomic neuropathy damages sensory afferents - impaired bladder sensation leads to chronic overdistension |
| Pernicious anemia | Subacute combined degeneration affecting sacral sensory fibers |
| Multiple sclerosis | Can affect sacral pathways (less commonly causes atonic vs. spastic bladder) |
| Herpes zoster | Sacral root involvement (S2-S4) |
Structural/Obstructive Causes
- Prostatic hypertrophy - chronic outlet obstruction leads to repeated overdistension and eventual detrusor decompensation
- Severe cystocele in women
- Postoperative urinary retention (especially after pelvic/perineal surgery or spinal anesthesia)
Pharmacological Causes
- Anticholinergic drugs (tricyclic antidepressants, antihistamines e.g. diphenhydramine, antipsychotics)
- Sympathomimetics (pseudoephedrine)
- Opioids
Other
- Spinal shock (acute phase after suprasacral spinal cord injury) - the bladder is areflexic and acontractile, lasting 6-12 weeks (sometimes up to 1 year) before reflexes recover (Bradley & Daroff's Neurology)
- DIDMOAD syndrome (Wolfram syndrome) - urinary tract abnormalities including atonic bladder
- Neurosyphilis - Argyll Robertson pupils, absent reflexes, atonic bladder (Andrews' Diseases of the Skin)
Clinical Features
- Urinary retention - inability to void despite a full bladder
- Overflow incontinence - constant dribbling of small amounts of urine as pressure overcomes sphincter resistance
- Large post-void residual (PVR) volume
- Absent or reduced urge to void (impaired bladder sensation)
- Bladder distension - palpable/percussible suprapubic mass
- Absent bulbocavernosus and cremasteric reflexes if peripheral sacral fibers are involved
- Predisposition to recurrent UTIs, ureteral reflux, hydronephrosis, and renal calculi
Urodynamic findings: Low bladder pressures, absent or reduced EMG activity, absent detrusor contractions, high PVR, no uninhibited contractions.
Comparison: Atonic Bladder vs. Detrusor-External Sphincter Dyssynergia (DESD)
| Feature | Atonic Bladder | DESD |
|---|---|---|
| Reflex status | Areflexic / hyporeflexic | Detrusor overactivity |
| Lesion location | Below conus medullaris (LMN) | Above conus medullaris (UMN) |
| Detrusor-sphincter coordination | Coordinated | Incoordinated |
| Bladder pressures | Low | High |
(Bradley & Daroff's Neurology in Clinical Practice)
Treatment and Management
1. Acute Phase (Spinal Shock)
- Insert a Foley catheter or begin clean intermittent catheterization (CIC) immediately to prevent overdistension
- CIC every 4 hours, keeping bladder volumes < 500 mL
- Monitor for recovery of bladder reflexes over 6-12 weeks
2. Bladder Emptying - Primary Methods
Clean Intermittent Catheterization (CIC) - the preferred long-term method
- Avoids the high complication rates of indwelling catheters (infection, bladder cancer, renal stones, strictures, diverticula)
- Performed every 4-6 hours
- Self-catheterization is ideal when the patient has adequate hand function and motivation
Manual / Physical Maneuvers (for LMN injuries)
- Credé maneuver: Manual direct pressure over the suprapubic area to express urine
- Valsalva maneuver: Increases intraabdominal pressure to assist voiding
- These are used when CIC is not feasible
Indwelling catheter (temporary)
- For patients who lack motivation, have limited hand function, or cannot receive adequate caregiver support
- Long-term use is discouraged due to complications
3. Pharmacological Treatment
| Drug | Mechanism | Use |
|---|---|---|
| Bethanechol (Urecholine) | Direct muscarinic (cholinergic) agonist - stimulates detrusor contraction | Atonic/flaccid bladder; postoperative retention; diabetic neurogenic bladder; alternative to chronic catheterization. Dose: 10-50 mg tid/qid orally |
| Alpha-blockers (tamsulosin, prazosin) | Relax bladder neck/internal sphincter | Facilitate voiding in patients with outlet resistance |
| Anticholinergics (oxybutynin, tolterodine) | Muscarinic antagonist - relax detrusor | Used for the spastic variant; NOT indicated in atonic bladder |
(Adams & Victor's Principles of Neurology; Goodman & Gilman's Pharmacological Basis)
4. Treat the Underlying Cause
- Diabetes: Optimize glycemic control to slow autonomic neuropathy progression
- Syphilis (tabes dorsalis): Penicillin treatment
- BPH: Alpha-blockers, 5-alpha reductase inhibitors, or transurethral resection of prostate (TURP)
- Drug-induced: Discontinue offending agent where possible
5. Prevention of Complications
- Urinary tract infections: Maintain hygiene with CIC; treat infections promptly; prophylactic antibiotics are controversial
- Upper tract protection: Monitor for hydronephrosis and vesicoureteral reflux with imaging; determine detrusor leak-point pressure (DLPP - threshold: 40 cmH2O)
- Renal function monitoring: Regular creatinine, renal ultrasound
6. Surgical Options (When Conservative Treatment Fails)
| Procedure | Indication |
|---|---|
| Sacral nerve stimulation (S2-S4) | Promotes bladder contraction; also used in Fowler syndrome |
| Selective posterior sacral rhizotomy | Suppresses hyperreflexic detrusor activity (more for spastic type) |
| Augmentation enterocystoplasty | Increases bladder capacity using a bowel segment; complications include metabolic derangements and changes in bowel habits |
| Detrusor myomectomy | Alternative augmentation by creating a diverticulum |
| Urinary diversion (ileal conduit) | External drainage via abdominal wall for refractory cases, females with urethral complications, or bladder cancer |
| Bladder neck closure + suprapubic catheter | Definitive management in selected neurogenic bladder patients |
| Transurethral sphincterotomy | Preferred for DESD refractory to anticholinergics (mainly males with quadriplegia) |
(Bradley & Daroff's Neurology in Clinical Practice; Hinman's Atlas of Urologic Surgery)
Summary Table
| Aspect | Key Points |
|---|---|
| Definition | Areflexic/hypotonic detrusor; inability to contract; overflow incontinence |
| Lesion | LMN - sacral cord (S2-S4), dorsal roots, or peripheral nerves |
| Key causes | Sacral SCI, cauda equina, DM neuropathy, tabes dorsalis, drugs, overdistension |
| Urodynamics | Low pressure, absent contractions, high PVR, no EMG activity |
| First-line Rx | CIC every 4-6 hours |
| Drug of choice | Bethanechol (cholinergic agonist) |
| Complication prevention | Monitoring for UTI, reflux, hydronephrosis, renal injury |
Sources:
- Guyton & Hall Textbook of Medical Physiology - Abnormalities of Micturition
- Bradley & Daroff's Neurology in Clinical Practice - Spinal Cord Injury and Bladder Function
- Adams & Victor's Principles of Neurology - Therapy of Disordered Micturition
- Goodman & Gilman's Pharmacological Basis of Therapeutics - Bethanechol
- Neuroanatomy through Clinical Cases 3rd Ed. - Bowel, Bladder, and Sexual Function
- Recent review: Neurogenic Lower Urinary Tract Dysfunction (Wiener & Chaudhry, Urol Clin North Am, 2023 - PMID 37385704) and The Ideal Neurogenic Bladder Management Team (Hogue & Kennelly, Urol Clin North Am, 2024 - PMID 38609201)
This is a shared conversation. Sign in to Orris to start your own chat.